• Open $38.88
  • Day Range 37.57 - 39.56
  • 52 Week Range 13.23 - 70.00
  • Market Cap $1.33B
  • Shares Outstanding 34.46M
  • Public Float 27.48M
  • Beta 0.72
  • Rev. per Employee $129.44K
  • P/E Ratio N/A
  • EPS -$3.19
  • Yield N/A
  • Dividend N/A
  • Ex-Dividend Date N/A
  • Short Interest 3.73M 08/13/21
  • % of Float Shorted 13.58%
  • Average Volume 238.5K
5 Day
  • -0.10%
1 Month
  • 22.23%
3 Month
  • 45.12%
YTD
  • -18.55%
1 Year
  • 152.59%

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The firm offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.